FDA.reportPublic FDA data

ergotamine tartrate 2 MG Sublingual Tablet

RxCUI
1293862
RxNorm name
ergotamine tartrate 2 MG Sublingual Tablet
Display name
Ergotamine (Sublingual)
Full name
ergotamine tartrate 2 MG Sublingual Tablet
Term type
SCD
Status
Active
Strength
2 mg
Dose form
Tab
Route
Sublingual
Updated
2026-10-30 15:30:29

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062012
Active start
062012
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ergotamine tartrate2 MG / 1 EACHergotamineergotamine tartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Sublingual Tablet317007

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ergotamine4025

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRergotamine tartrate 2 MG Sublingual Tablet1NAMES
RxNorm Nameergotamine tartrate 2 MG Sublingual Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI12938621CODES
MMSL_CODECD36981CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 9 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00052054724rxnav_historical_indirect
00071011113rxnav_historical_indirect
00585012020rxnav_historical_indirect
10802120200rxnav_historical_indirect
10802120202rxnav_historical_indirect
46672080200rxnav_historical
59417012020rxnav_historical_indirect
67754012002rxnav_historical_indirect
67754012020rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ergomar SublingualERGOTAMINE TARTRATEPangea Pharmaceuticals LLCa9582fdb-7ddd-4f69-aa7a-66247cdb8c922025-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1293862

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a9582fdb-7ddd-4f69-aa7a-66247cdb8c92ergotamine tartrate 2 MG Sublingual Tablet [PSN] · ergotamine tartrate 2 MG Sublingual Tablet [SCD]22Ergomar ® Sublingual Tablets, 2 mg20250225

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f55ef9b6-3068-4c8c-aa5d-920fea54ceb4National Council for Prescription Drug Programs20130213
1bfd4827-5123-4dbb-8f94-7b097f5bfd5cErgomar® Sublingual Tablets, 2 mg (Ergotamine Tartrate Sublingual Tablets, USP)Rosedale Therapeutics | Mikart, Inc.20120908

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02CAErgot alkaloidsATC1-4ergotamine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine tartrate
MEDRTD002219CarbamatesCHEMci_chemclassergotamine tartrate
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine tartrate
MEDRTD005663FuransCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD019888NelfinavirCHEMci_chemclassergotamine tartrate
MEDRTD019438RitonavirCHEMci_chemclassergotamine tartrate
MEDRTD013449SulfonamidesCHEMci_chemclassergotamine tartrate
MEDRTD000033Abortion, ThreatenedDISEASEci_withergotamine tartrate
MEDRTD000788Angina Pectoris, VariantDISEASEmay_diagnoseergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine tartrate
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine tartrate
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD006973HypertensionDISEASEci_withergotamine tartrate
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine tartrate
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine tartrate
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD006473Postpartum HemorrhageDISEASEmay_preventergotamine tartrate
MEDRTD006473Postpartum HemorrhageDISEASEmay_treatergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD011247PregnancyDISEASEci_withergotamine tartrate
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTD018805SepsisDISEASEci_withergotamine tartrate
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine tartrate
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine tartrate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine tartrate
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008376Cutaneous Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH2 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESSNOMEDCT370211007
CODESVUID4005093
NAMESPrescribable Synonymergotamine tartrate 2 MG Sublingual Tablet
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File